The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal radiation therapy.
Diabetic retinopathy is a major neurovascular complication of diabetes that affects 7.7 million working-age adults in the United States.
Traditional stroke treatments like clot-dissolving tPA and surgical removal of big clots in the brain are good choices as well when the stroke results from SARS-CoV-2 infection, investigators report.
Lynn Tran, a student in the University System of Georgia MD/PhD program at the Medical College of Georgia at Augusta University, has received a Louise McBee Scholarship from the Georgia Association for Women in Higher Education.
Women who don’t survive this rare and aggressive uterine cancer have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.
Paul Tran is working to develop a highly predictive genetic risk score that will tell parents whether their baby is at significant risk for type 1 diabetes.
Dr. Jin-Xiong She recently received a fourth renewal on the TEDDY study, which is working to find out how genetics and environmental factors collide and lead to the development of type 1 diabetes in some children.
From allergies to sickle cell anemia to diabetes, research at Augusta University is paving the way for kids to lead healthier lives.
Researchers think the prevention of inflammation will help prevent or delay diabetic kidney disease and probably other consequences of type 1 diabetes.
Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.
The TEDDY study’s international research team has identified the new gene regions in young people who have already developed type 1 diabetes or who have started making antibodies against their insulin-producing cells, often a precursor state to the...
Scientists have engineered a sort of biological barbell that can get inside cancer cells and do damage to two proteins that work independently and together to enable cancer’s survival and spread. Their therapeutic strategy includes a molecule on...